Universe Pharmaceuticals (UPC) Debt to Equity: 2020-2024
Historic Debt to Equity for Universe Pharmaceuticals (UPC) over the last 5 years, with Sep 2024 value amounting to $0.18.
- Universe Pharmaceuticals' Debt to Equity fell 10.37% to $0.18 in Q3 2024 from the same period last year, while for Sep 2024 it was $0.58, marking a year-over-year increase of 13.87%. This contributed to the annual value of $0.18 for FY2024, which is 10.37% down from last year.
- Per Universe Pharmaceuticals' latest filing, its Debt to Equity stood at $0.18 for FY2024, which was down 10.37% from $0.20 recorded in FY2023.
- Over the past 5 years, Universe Pharmaceuticals' Debt to Equity peaked at $45,979 during FY2020, and registered a low of $0.00 during FY2021.
- In the last 3 years, Universe Pharmaceuticals' Debt to Equity had a median value of $0.18 in 2024 and averaged $0.16.
- In the last 5 years, Universe Pharmaceuticals' Debt to Equity crashed by 100.00% in 2021 and then skyrocketed by 22,689.02% in 2022.
- Universe Pharmaceuticals' Debt to Equity (Yearly) stood at $45,979 in 2020, then tumbled by 100.00% to $0.00 in 2021, then spiked by 22,689.02% to $0.10 in 2022, then spiked by 104.93% to $0.20 in 2023, then declined by 10.37% to $0.18 in 2024.